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The recombinant E1E2 heterodimer of the hepatitis C virus is a candidate for a subunit vaccine. Folding analysis of E1 and E2
glycoproteins, stably expressed in CHO cells, showed that E1 folding was faster and more efficient than E2. The oxidized DTT-resistant
conformation of E1 was completed within 2 h post-synthesis, while E2 not only required up to 6 h but also generated non-native species.
Calnexin was found to assist E1 folding, whereas no chaperone association was found with E2. The assembly of E1 and E2 was assessed by
co-immunoprecipitation and sedimentation velocity analysis. We found that the formation of native E1E2 heterodimers paralleled E2
oxidation kinetics, suggesting that E2 completed its folding process after association with E1. Once formed, sedimentation of the native E1E2
heterodimers was consistent with the absence of additional associated factors. Taken together, our data strongly suggest that productive
folding of the major HCV spike protein E2 is assisted by E1.
D 2004 Elsevier Inc. All rights reserved.
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The hepatitis C virus (HCV) is the only member of the
hepacivirus genus, a genus that belongs to the Flaviviridae
family (Lindebach and Rice, 2001). All members of this
family, which includes the flavi- and the pestiviruses, have
three structural proteins: one capsid and two envelope
proteins (preM/M or E1 and E or E2) all derived from the
N-terminus region of a polyprotein (Burke and Monath,
2001; Lindebach and Rice, 2001). The envelope proteins are
targeted to the endoplasmic reticulum (ER) by signal
sequences in the preceding polypeptide and co-translation-0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2004.11.034
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E-mail address: marcello_merola@chiron.com (M. Merola).ally separated from each other by host signal peptidase
cleavages. They remain anchored to the ER membrane
through a hydrophobic sequence located at their COOH-
terminus. In the majority of the flaviviridae viruses, the
envelope proteins acquire one or more N-linked oligosac-
charide chains. The ER, or an ER-derived compartment, is
thought to be the site where these viruses bud. In HCV and
pestiviruses, an additional peptide of the structural region, p7,
is generated inefficiently by the signal peptidase from the C-
terminus of the E2 precursor (Lin et al., 1994; Lindebach and
Rice, 2001; Mizushima et al., 1994). Assembly of the HCV
glycoproteins results in the formation of non-covalently
linked E1E2 heterodimers, thought to be the functional units
of the HCV spike (Dubuisson et al., 1994).
While providing assistance to newly synthesized proteins
during post- and co-translational folding, the ER also05) 438–453
M. Brazzoli et al. / Virology 332 (2005) 438–453 439submits them to strict quality control (Ellgaard et al., 1999;
Fewell et al., 2001). Formation of native disulfide bonds is
promoted by the oxidizing environment and the presence of
thiol oxidoreductases, generation of aggregates is prevented
by chaperones, and native conformation is checked by
folding sensors (Fassio and Sitia, 2002; Parodi, 2000;
Wickner et al., 1999). Although individual proteins can
make use of specialized chaperones or escort proteins, virus
envelope glycoproteins are commonly found to associate
transiently with two types of chaperones (and associated
oxidoreductases): calnexin/calreticulin with ERp57 and BiP
together with PDI (Molinari and Helenius, 2000; Oliver et
al., 1999).
Viral glycoproteins already undergo processing in the ER
before they reach their native structure and, apart from the
assistance by host chaperones, there is growing evidence
that they may influence each other’s folding (Andersson et
al., 1997; Guirakhoo et al., 1992; Konishi and Mason, 1993;
Lorenz et al., 2002). Previous studies on the folding of HCV
glycoproteins pointed to the major spike protein E2 as
essential for the folding of the minor glycoprotein E1
(Michalak et al., 1997). On the other hand, E1 expressed in
absence of E2 in an in vitro system appeared properly
oxidized and released from chaperones (Merola et al.,
2001).
While full length and truncated forms of E2 were
originally reported to fold without E1 (Dubuisson and Rice,
1996; Michalak et al., 1997), more recent studies indicate
that E2 cannot reach a native structure in absence of E1.
First, the appearance of conformational epitopes on E2 was
found to be slow, suggesting that the conformational
maturation of E2 could be the limiting step in the formation
of native heterodimers (Deleersnyder et al., 1997). Second,
E2 expressed alone in mammalian cells was not recognized
by a human conformational antibody and showed a weaker
binding to the putative HCV receptor CD81 (Cocquerel et
al., 2003a, 2003b). Third, analysis of HCV proteins
generated in insect cells, as virus like particles (VLPs) or
purified proteins, displayed antigenic differences between
truncated E2 and E1E2 complexes, although binding to
CD81 did not appear to be affected (Chan-Fook et al.,
2000). Fourth, the infectivity of the recently developed
hepatitis C virus pseudo-particles in retroviral and lentiviral
systems, relied completely on co-expression of both E1 and
E2, although individual E1 or E2 were efficiently incorpo-
rated in the particles (Bartosch et al., 2003; Hsu et al.,
2003). Finally, even though the role of neutralizing anti-
bodies in the resolution of HCV infection is still unclear, in
terms of protective immunity, the efficacy of the purified
E1E2 heterodimer has been proven in the chimpanzee
challenge model (Houghton and Abrignani, 2004).
Here, we report on the folding and dimerization of E1
and E2 glycoproteins constitutively expressed in CHO cells.
We found that oxidative folding of E1 was considerably
faster than that of E2. The slow folding kinetics of E2
paralleled E1E2 heterodimer formation, indicating that E2folding represented the limiting step in glycoprotein
assembly in the ER. The sedimentation profile of E1, E2,
and E1/E2 heterodimers suggested that E1 and E2 fold
together in a complex where the folding of E1 precedes that
of E2.Results
Folding and dimerization of HCV glycoproteins were
studied in CHO cells stably transfected with a construct
expressing E1, E2, and p7 proteins (CHO-E1E2p7) of the
HCV 1a strain. Following pulse-chase, an immunopreci-
pitation step was required for E1 and E2 folding and
assembly analysis. The oxidation status of such proteins
was evaluated on SDS-PAGE based on electrophoretic
mobility differences between fully and partially oxidized
proteins under non-reducing conditions (Braakman et al.,
1991; Selimova et al., 1982). We will refer to samples
analyzed with added DTT in the loading buffer as reduced
(red). As to proteins analyzed under non-reducing con-
ditions, we will refer to them as oxidized (ox) or
unoxidized (unox) species to indicate conformers that
have or have not formed detectable intra-chain disulfide
bonds, respectively.
Kinetics of E1 and E2 oxidation in CHO-E1E2p7
To study the behavior of newly synthesized E1 and E2,
CHO-E1E2p7 cells were pulse-labeled for 20 min and
chased for different periods of time. Figs. 1 and 2 show
oxidative status, endoglycosidase H (endoH) sensitivity and
DTT-resistance of E1 and E2 immunoprecipitated using the
a-E1E2 Ch-L559 antiserum that recognizes reduced,
unoxidized and oxidized forms of HCV glycoproteins.
Panel A of Fig. 1 shows the oxidation status of E1 and
E2 from 20 min through 6 h. The E1 protein has a simpler
oxidation pattern with a single faster migrating band of
increasing intensity over a period of 2 h (Fig. 1A, lanes 2–4,
E1ox). A parallel decrease in the intensity of the slower
migrating form (E1unox) is observed until it disappears
almost completely at 2 h. Following reduction of the
samples, only one band was visible on the gel (lanes 8–12
of Fig. 1A) whose migration parallels the unoxidized E1
(compare lanes 2–3 and 8–9 of Fig. 1A). This time-
dependent increased mobility of E1 was consistent with
the progressive formation of intrachain disulfide bonds. A
gradual decrease in the apparent molecular weight of E1
under reducing conditions can also be noticed (lanes 8–12).
This was caused by ER-type trimming of the N-linked
oligosaccharides (see below). The oxidation process of E2
(and E2p7, as discussed below) emerging from Fig. 1A was
less straightforward. This was due to the simultaneous
presence of the E2 and the E2p7 precursor and of their
differentially oxidized and trimmed conformers together
with the variable saccharides trimming status of the different
Fig. 1. Oxidation kinetics and endoH sensitivity of HCV glycoproteins E1 and E2. CHO cells stably transfected with a construct expressing E1, E2 and p7
(CHO-E1E2p7) were pulse-labeled with [35S] methionine and cysteine for 20 min and chased for different time periods, as reported in Materials and methods.
PNSs were immunoprecipitated with an anti-E1/E2 antiserum (Ch-L559) and analyzed on SDS-PAGE. The asterisks mark the location of non-specific bands.
The symbols refer to different forms of E1 and E2: unox for unoxidized; ox for oxidized; red for reduced; pr for protein precursor; Dglc for deglycosylated
protein, n for non-transfected CHO cells. Position on gels of pre-stained Molecular Weight markers (Biorad) is reported on the right side. (A) Chase periods are
indicated above the lanes. Samples are analyzed on 10% SDS-PAGE under non-reducing (lanes 1–6) and reducing (lanes 7–12) conditions. (B) Aliquots of the
SDS resuspended immunocomplexes were submitted to digestion with endoH (+) or treated in the same conditions but without the enzyme (). Samples were
separated on 12.5% SDS-PAGE in reducing conditions. (C) CHO-E1E2p7 (C809) and CHO-E1E2 (C746) cells were metabolically labeled for 4 h in presence
of [35S] methionine and cysteine. The E1 and E2 proteins were immunoprecipitated from the PNS with Ch-L559 antiserum and treated (+) or not () with
endoH. Proteins were then separated on 12.5% SDS-PAGE in reducing conditions.
M. Brazzoli et al. / Virology 332 (2005) 438–453440species. The overall effect on SDS-PAGE migration was a
broad range of apparent MWs already reported in the
literature (Grakoui et al., 1993; Ralston et al., 1993). Thus,
although we observed a gradual shift in the mobility of theE2 band through the entire 6 h period of chase in both non-
reduced (Fig. 1A, lanes 2–6), and reduced lanes (Fig. 1A,
lanes 8–12), a clear oxidation kinetics of E2 was obtained
only after removal of the sugar moiety, as shown below. It is
Fig. 2. DTT-resistance analysis of HCV proteins E1 and E2. CHO-E1E2p7 cells were pulse-labeled and chased for the indicated time periods, in duplicates.
One of the dishes in each pair was chased for an additional 5 min in presence of 5 mM DTT (+) in the culture media before proceeding with lysis. PNSs were
immunoprecipitated with anti-E1/E2 antiserum Ch-L559. (A) Upper panel, E2 protein. Lower panel, E1 protein. The samples were analyzed on 10% SDS-
PAGE under reducing and non-reducing conditions. (B) Immunoprecipitated proteins were treated with endoH in non-reducing conditions, as indicated in
Materials and methods. Symbols ox and red refer to oxidized and reduced species respectively, ITs refers to oxidative intermediates.
M. Brazzoli et al. / Virology 332 (2005) 438–453 441noteworthy that at 20 min E2 appeared already partially
oxidized (Fig. 1A, compare lanes 2 and 8).
Because the gel shown in Fig. 1A represented the
bprototypeQ gel, we wish to state some general points. First,
the presence of relatively few high molecular weight
aggregates indicated that the majority of the HCV glyco-
proteins did not generate disulfide cross-linked aggregates.
Second, due to its size and its reactivity with both anti-E1
and anti-E2 antibodies, the 100-kDa band was tentatively
identified as an unprocessed E1E2 precursor possibly
containing also p7 (data not shown). The presence of this
species has been reported previously (Choukhi et al., 1999).
Third, to rule out the formation of detergent-insoluble high
molecular weight aggregates, we also analyzed the pellet
fractions at each time of chase for the presence of HCV
glycoproteins. Following SDS solubilization and Triton X-
100 quenching of the proteins, Ch-L559 immunoprecipita-
tion revealed the presence of only traces of E1 and E2
proteins, indicating the absence of time-dependent aggre-
gate formation (data not shown).
Next, we submitted Ch-L559 immunoprecipitated sam-
ples to endoH digestion in reducing condition to: (i) exclude
the presence of cleavages of the polypeptide moiety that
could result in the faster electrophoretic migration; (ii)
evaluate the presence of the E2p7 precursor; and (iii) verify
whether the sugar moiety of both E1 and E2 underwent
post-ER modifications. As shown in Fig. 1B, both E1 and
E2 proteins migrated considerably faster after endoH
digestion (compare odd and even lanes of Fig. 1B) without
visible shift during the entire chase period. Furthermore, we
unequivocally identified the bands corresponding to E2 and
the E2p7 precursor by comparing with endoH digestion of
immunoprecipitated PNS from pulse-chased CHO cellsexpressing E1E2 (ending at aa 746) free from the p7
polypeptide (Fig. 1C). The slow and incomplete cleavage of
p7 was estimated by densitometric analysis of the relative
amount of E2p7 and E2. The amount of full-length E2
increased from 30% at 20 min to 45% and 61% at 1 and 2 h,
respectively (even lanes). At later times, the process was
slower since the amount of E2 was 63% at 4 h and 67% at 6
h. The endoH sensitivity of both E1 and E2 was consistent
with retention in a pre-Golgi compartment, at least for 6 h
after synthesis. These data were also confirmed by
immunofluorescence experiment on semi-permeabilized
CHO-E1E2p7 cells (data not shown).
DTT-sensitivity and endoH digestion of HCV glycoproteins
in non-reducing conditions
When added to cells, DTT blocks disulfide bond
formation in the ER and particularly in incompletely folded
proteins (Braakman et al., 1992; Kaji and Lodish, 1993;
Lodish and Kong, 1993; Tatu et al., 1993). If disulfide
bonds were not accessible—a strong indication of native
structure formation—the protein would migrate as the
oxidized species. Conversely, the DTT-sensitive species
collapsed upon reduction to the same position as the reduced
or partially oxidized proteins. We evaluated the DTT-
sensitivity of E1 and E2 on the basis of SDS-PAGE
migration in non-reducing conditions by comparing samples
derived from untreated and DTT-treated cells. The results
from these experiments are shown in Fig. 2.
Once again, E1 showed a simpler pattern. Quantification
by densitometric analysis showed that, although 20 min
after synthesis nearly the entire pool of E1ox was DTT-
sensitive (Fig. 2A, left bottom panel, lanes 1–2), within 2 h,
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bottom panel, lanes 5–10). After 1 h of chase, the amount of
oxidized E1 was 53% after DTT addition compared to 73%
in absence of treatment (Fig. 2A, left bottom panel, lanes 3–
4). The corresponding reduced samples (right bottom panel
of Fig. 2A) migrated as single band showing sugar
trimming.
The DTT-sensitivity of E2 and the E2p7 precursor in
the same conditions was much less resolved (Fig. 2A,
upper panel). Although it appeared that the E2 DTT-
resistance was achieved at later chase times than E1, it
was not possible to separate E2, E2p7, their oxidizing
conformers and the differentially trimmed species. In
particular, we found that glycan chains represented the
major problem, since separation of these glycoproteins in
gels with a lower acrylamide concentration did not
improve the identification of the different species (data
not shown). To achieve a better resolution, immunopreci-
pitated samples were digested with endoH in non-reducing
conditions before proceeding to SDS-PAGE analysis. The
result of this experiment is shown in Fig. 2B. At 20 min
of chase, E2 and E2p7 showed a large band and a diffuse
smear that was resolved in two distinct bands in samples
derived from DTT-treated cells (Fig. 2B, lanes 1–2). The
two bands in lane 2 corresponded to E2 and the E2p7
precursor and they migrated to the same position of the
reduced samples (Fig. 2B, compare lanes 2 and 12). Thus,
early folding E2 intermediates were completely DTT-
sensitive. After 1 h chase, a faster migrating E2ox band
formed, but it disappeared in the corresponding exoge-
nously reduced sample (Fig. 2B, left panel, lanes 3–4).
The smear between the E2ox and E2red bands was likely to
represent E2 folding intermediates (ITs). Starting from 2 h
chase, the E2ox band was the major species and became
sharper but DTT-resistance acquisition proceeded more
slowly (Fig. 2B, lanes 5–6). Although an accurate
densitometric analysis was difficult due to the high
background, we calculated that roughly 50–60% of E2ox
was DTT-sensitive at 2 h. After 4-h chase, the fully
oxidized E2 band was still partially DTT-resistant. Only
after 6 h the process was completed (Fig. 2B, lanes 7–10).
Opposite to E2, the E2p7 precursor did not show a clear
oxidation pathway. At 4 h chase, no sharp bands
corresponding to E2p7ox were visible whereas E2 was
mostly in the oxidized conformation (Fig. 2B, lanes 7 and
9). Even more, at 6-h chase, the E2p7red band disappeared
from the sample derived from DTT-treated cells (Fig. 2B,
lane 10). We concluded that E2p7 did not show a major
oxidation pathway but generated a series of intermediates
resolved as a smeared area on the gel. These intermediates
were completely DTT-resistant 6 h from the synthesis,
suggesting that the E2p7 precursor acquired a series of
misfolded conformations in which it remained trapped.
The corresponding reducing lanes showed the presence of
the E2 and E2p7 bands migrating to unmodified positions
(Fig. 2B, lanes 11–20).Immunoprecipitation with conformational anti-E2
monoclonal antibodies (mAbs)
It was previously found that the two HCV glycoproteins
form a strong heterodimer complex with no intersubunit
disulfide bonds (Dubuisson et al., 1994; Ralston et al., 1993).
To analyze the formation of the heterodimer in our system,
we used different anti-E2 conformational mAbs in immu-
noprecipitation of pulse-chased PNSs and checked for the
presence of co-immunoprecipitated E1. Fig. 3 shows the
results obtained using an anti-E2 antibody, the human mAb
CBH-2 (Hadlock et al., 2000). This antibody was represen-
tative of several others we used, such as the human derived
CBH-5, -7, -8c, and -11 (Hadlock et al., 2000) or the mouse
mAb 291 (Rosa et al., 1996). Although a deeper analysis of
each mAb is beyond the purposes of this work, we often
observed overlapping patterns of immunoprecipitation with
minor differences in efficiency at early and late times of
chase (30–45 min and 4–6 h, unpublished data). Further
studies are needed to elucidate whether such differences are
due to a higher affinity of some antibodies or to kinetically
differential formation of the relative epitopes.
Fig. 3A shows a representative SDS-PAGE in reducing
conditions of HCV E1 and E2 immunoprecipitated by CBH-
2 mAb and their endoH digestion. The formation and the
recognition of the conformational epitopes start late after
protein synthesis (45 min chase) and the E2 species always
carried down E1, representing the formation of E1E2
heterodimers (Fig. 3A, odd lanes). The endoH-treated E2
clearly showed the presence of the E2p7 precursor (Fig. 3A,
even lanes), demonstrating that both the E2p7 and the
mature E2 were able to attain structural determinants
recognized by conformational antibodies. Furthermore, the
relative intensity of the digested E2p7 and E2 at the different
chase periods (Fig. 3A, even lanes) showed that the p7
cleavage was slow and inefficient, as found previously using
the chimpanzee antiserum (Fig. 1B).
The formation of conformational epitopes and the
resistance of E1E2 heterodimers to external added DTT
were analyzed by treating the cells in parallel with and
without DTT, as described above. The amount of E1 and E2
was evaluated by normalizing the amount of PNSs used for
the immunoprecipitation, as indicated in Materials and
methods. Figs. 3B–D shows the SDS-PAGE and the graphs
derived from phosphoimager analysis of this experiment.
The appearance of conformational epitopes on E2
increased progressively during the first 4 h, showing a
minor drop at 6 h chase (Fig. 3B, upper panel, lanes 3, 5, 7,
9, 11 and corresponding graph in Fig. 3C). In parallel with
E2, the amount of co-immunoprecipitated E1 increased in
the same time-dependent manner, indicating that conforma-
tional epitope formation on E2 was contemporary or
subsequent to the E1E2 heterodimer formation (Fig. 3B,
lower panel, lanes 3, 5, 7, 9, 11 and Fig. 3C). Within 1 h
chase, the amount of conformational E2, as well as the E1E2
heterodimers, was very low (Fig. 3B, lanes 3–6 and Fig.
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Fig. 3. Anti-E2 conformational mAbs immunoprecipitation, endoH digestion and DTT-resistance analysis. CHO-E1E2p7 cells were pulse-labeled with [35S]
methionine and cysteine and chased for different time periods, as indicated above the lanes. PNSs were immunoprecipitated with anti-E2 conformational mAb
CBH-2. (A) Immunoprecipitated complexes were treated (+) or not () with endoH and analyzed on 12.5% SDS-PAGE in reducing conditions. (B) CHO-
E1E2p7 cells were pulse-labeled in duplicates. At the end of chase, one of the dishes of the pair was treated for an additional 5 min with 5 mM of DTT. Equal
amounts of labeled proteins were used for immunoprecipitation. The samples were analyzed on 10% SDS-PAGE in non-reducing (lanes 1–12) and reducing
(lanes 13–24) conditions. (C) The graph represents the amount of immunoprecipitated E1 and E2 revealed on SDS-PAGE in reducing conditions (B) calculated
by densitometric analysis (ImageQuant). (D) The graph shows the relative amount of immunoprecipitated E2 in presence (black bars) or in absence (white bars)
of DTT treatment. The lane in the graph represents the ratio between E2 samples treated (E2+) and not treated (E2) with DTT. Symbol Dglc is for de-
glycosylated proteins; red and ox refer to reduced and oxidized species, respectively.
M. Brazzoli et al. / Virology 332 (2005) 438–453 4433C). Indeed, the higher slope of immunoprecipitated E2 was
observed between 1 and 2 h chase, a period that fit with the
increased formation of E2ox detected with the chimpanzee
antibody (Fig. 2A). Furthermore, both the E1 and E2
proteins appeared to be fully oxidized, as evidenced by
comparing their migration in non-reducing and reducing
conditions (Fig. 3B, left versus right panel). The compara-tive kinetics of the total conformational E2 versus its DTT-
resistant fraction is also shown in Fig. 3B, and the
quantitative analysis of the gel is reported in the graph of
Fig. 3D. Within 2 h chase, the amount of immunoprecipi-
tated E2 visibly decreased after cell treatment with the
reducing agent (Fig. 3B, compare even and odd lanes). In
parallel, the intensity of co-immunoprecipitated E1
M. Brazzoli et al. / Virology 332 (2005) 438–453444decreased by the same intensity. Between 4 and 6 h chase,
almost the whole E2 population acquired full DTT-
resistance, indicating that the oxidation process was
completed (Fig. 3B, lanes 9–12 and Fig. 3D). These
observations evidenced that (1) the conformational anti-E2
mAb was able to recognize both DTT-resistant and DTT-
sensitive populations of oxidized E2, (2) the E1E2 hetero-
dimers included both DTT-sensitive and DTT-resistant E2,
and (3) the E2 molecule achieved the DTT-resistant
conformation while already associated with E1. It is also
worth to note that, whereas the E2p7 precursor was
recognized by the anti-E2 CBH-2 antibody and it was
likely associated with E1, the absence of a conformational
anti-E1 antibody did not allow us to verify this assumption.
Association and release of HCV glycoproteins E1 and E2
with ER chaperone calnexin
To further analyze the folding of these proteins, we have
checked their association with the principal ER chaperones.
It is well established that all membrane glycoproteins areFig. 4. E1 and E2 co-immunoprecipitation by anti-calnexin antibody. (A) NaRve
methionine and cysteine and chased for different time periods, as indicated abo
immunoprecipitated with anti-E1 and -E2 antiserum Ch-L559 (lanes 3, 6, 9, 12) or
were immunoprecipitated with anti-calnexin antiserum (lanes 1, 3, 5, 7). Immu
reducing (upper panel) and reducing (lower panel) conditions. n is for naRve CHO
oxidized and reduced species, respectively. (B) CHO-E1E2p7 cells were pulsed fo
mM DTT. Cells were then chased in absence of DTT and, where indicated, in pres
E1E2 antiserum Ch-L559 (lanes 1, 3, 5, 7), or co-immunoprecipitated by anti-caln
PAGE analysis.subjected to ER-quality control, and that only properly
folded and assembled species are released from chaperone
association (Ellgaard et al., 1999). It has previously been
reported that over-expressed E1 and E2 associate with ER
chaperone calnexin, calreticulin and BiP but not with
GRP94 (Choukhi et al., 1998; Dubuisson and Rice, 1996).
We have checked the association of HCV proteins with
these same chaperones in CHO-E1E2p7 cells. PNSs from
pulse-chased cells were divided into two aliquots, one of
which immunoprecipitated with anti-E1–E2 antiserum Ch-
L559 and the other with the corresponding anti-chaperone
antibody. We were able to detect only a clear transient
interaction of E1 with calnexin (Fig. 4A). At early times of
chase, E1 was present almost exclusively in an unoxidized
conformation that was recognized by calnexin (Fig. 4A,
lanes 2 and 3 of the upper panel). In the sample chased for 1
h, two E1 bands appeared in non-reducing conditions: a
slower migrating unoxidized E1 still bound to calnexin and
a faster migrating oxidized species that was not associated
with the chaperone (Fig. 4A, lanes 5 and 6 of the upper
panel). After a 2 h chase, the whole pool of E1 underwentCHO and CHO-E1E2p7 cells were pulse-labeled for 20 min with [35S]
ve the lanes. PNSs from CHO-E1E2p7 were divided in two aliquots and
with anti-calnexin antiserum (lanes 2, 4, 6, 8). PNSs from CHO naRve cells
noprecipitated complexes were analyzed on 10% SDS-PAGE under non-
cells, E1E2p7 for CHO-E1E2p7 cells; unox, ox, and red are for unoxidized,
r 20 min with [35S] methionine and cysteine, in duplicate, in presence of 5
ence of 1 mM castanospermine (CST). E2 was immunoprecipitated by anti-
exin antiserum (lanes 2, 4, 6, 8). Samples were then treated for 10% SDS-
M. Brazzoli et al. / Virology 332 (2005) 438–453 445oxidation and calnexin release (Fig. 4A, upper panel, lanes 8
and 9). The pattern did not change at later times of chase
(Fig. 4A, upper panel, lanes 11 and 12). Comparative
analysis of the samples in reducing and non-reducing
conditions revealed additional details (Fig. 4A, upper and
lower panel). First, a minor population of slower migrating
E1 was still associated with calnexin at late time of chase
(Fig. 4A, lanes 2, 5, 8, 11) although the anti-E1–E2
antiserum did not recognize these species (Fig. 4A, lanes
3, 6, 9, 12). Our hypothesis is that it represented a
population of E1 driven to a mis-folded pathway, thus
missing recognizable epitopes but still chaperoned by
calnexin. Second, electrophoresis in reducing conditions
revealed that at early time of chase (20 min and 1 h) the
ChL559 immunoprecipitated E1 was a mixed population
mainly composed of one slower and one faster migrating
band (Fig. 4A, lower panel, lanes 2–3 and 5–6). At late
times of chase, only the faster migrating band was left (Fig.
4A, lower panel, lanes 8–9 and 11–12). This observation is
consistent with the mechanism of calnexin association with
glycoproteins that requires the presence of the innermost
glucose on the high mannose oligosaccharide chain (Ell-
gaard et al., 1999; Parodi, 2000). On E1 there are up to four
glycan chains, the glucose residue of which could not only
retain calnexin association but also account for the slower
migration of E1 in reducing conditions. On the other hand, a
reduced apparent molecular weight of the calnexin-released
E1 was consistent with the complete removal of the
glucoses, indicating that the protein had reached its native
conformation.
We have not been able to co-precipitate the E2 protein
with any of the anti chaperone antibodies employed using a
variety of cell lysis conditions, salt compositions and
concentrations, detergents and pHs (data not shown). To
determine whether there might be a fast co-translational
cycle of association-dissociation completed during the pulse
period or immediately thereafter, we designed an experi-
ment in which DTT was used in the pulse period to impair
cysteines oxidation, followed by DTT washing to resume
the folding process. Castanospermine, a drug that blocks
glucose removal by inhibiting both glucosidase I and II, was
used in the chase medium to freeze the complex between E2
and calnexin and/or calreticulin. Two aliquots of PNSs at 20
min and 2 h chase were immunoprecipitated with the anti-
E2 antiserum and anti-calnexin and immunocomplexes
analyzed on SDS-PAGE. Only a very minor fraction of
E2 was pulled down by anti-calnexin antibody in the
castanospermine-treated cells but not in absence of this
inhibitor (Fig. 4B). No co-immunoprecipitated E2 was
detected using anti-calreticulin antibody (not shown).
Although the intensity of the E2 band associated with
calnexin was very low, this behavior was reproducible. The
amount of E2 trapped to calnexin did not increase from 20
min to 2 h chase (Fig. 4B, lower panel), indicating the
irrelevance of re-glycosylation by the UDP-glucose glucosyl
transferase. Taken together, these data indicated that, in oursystem, E2 association with calnexin was a co-translational
process followed by fast dissociation. This observation
implies that both the lectin chaperones and the UDP-
glucosyl transferase recognize incompletely oxidized E2
molecules as folding-competent.
Velocity sedimentation analysis of E1, E2, and E1E2
heterodimers
Our results from co-immunoprecipitation showed that
formation of relevant amounts of stable E1E2 heterodimers
initiated later than 1 h from the synthesis, accelerated
between 1 and 2 h and reached the maximum after 4 h
chase. To further characterize this process, as well as the
behavior of the different E1 and E2 species at different
periods post-synthesis, we performed a velocity sedimenta-
tion analysis in sucrose gradients. Each of the 20 collected
fractions was split in two identical aliquots and immuno-
precipitated with anti-E1–E2 antiserum Ch-L559 and anti-
E2 conformational antibody CBH-2. Fig. 5 shows the
SDS-PAGE in non-reducing conditions of anti-E1 and -E2
Ch-L559 immunoprecipitation and the corresponding
graphs generated by densitometric analysis. Sedimentation
analysis of E1 at 45 min chase showed the presence of a
broad peak ranging from 2.8 to about 7 S in which the
oxidized protein was enriched in the slower sedimenting
fractions, whereas fractions enriched with unoxidized E1
sedimented faster (Fig. 5, top panel). At this chase period, the
E2 sedimentation was faster than E1 and visibly broader,
showing at least three peaks. Once more, the slower
sedimenting E2 fractions were enriched with intermediates
in a more advanced status of oxidation. Therefore, it
appeared that the more oxidized conformers of both E1
and E2 sedimented in the same fractions and so did the
unoxidized ones. This observation could indicate that at
early time of chase, E1 and E2 went through multifaceted
interactions. The sedimentation pattern was much simpler
starting from 2 h of chase when, as shown previously, almost
only native E1 was present (Fig. 5). At 2 h post-synthesis,
both E1 and E2 sedimentation profiles showed two peaks. In
the slower sedimenting peak, the two glycoproteins were
shifted by one fraction, while in the faster migrating ones
they overlapped. At 4 h, both proteins showed one
coincident peak with maximum range between 3.7 and 5.5
S. At 6 h post-synthesis, this peak was still present but a new
faster sedimenting one appeared with a sedimentation
coefficient around 7.3 S.
We have already established that the anti-E2 CBH-2
mAb recognized only oxidized E2 and E2p7, most likely
associated with E1. The sedimentation pattern of these
species is shown in Fig. 6. At 45-min chase, a modest
amount of the heterodimer was detected that progressively
increased during the chase. As better visualized on the graph
of Fig. 6, the peak became sharper and the range of its
sedimentation coefficient shifted toward lower values from
4.6 S at 45 min after synthesis to 3.7 S at longer chase times.
Fig. 5. Velocity sedimentation analysis of Ch-L559 immunoprecipitated species. CHO-E1E2p7 cells were pulse-labeled with [35S] methionine and cysteine and
chased for different time periods, as indicated on the left side. PNSs were submitted to ultracentrifugation and the collected fractions were immunoprecipitated
with anti-E1E2 antiserum Ch-L559. Samples were then separated on 10% SDS-PAGEs in non-reducing and reducing conditions. Electrophoresis in non-
reducing conditions of Ch-L559 immunoprecipitated samples is shown on the left side. The right panels show the relative amount of E1 and E2 proteins
calculated out of 100% of the 19 fractions for each chase point. The arrows above the fractions indicate the S20,w sedimentation coefficient standards, as
determined by quantification of a velocity sedimentation gradient run with protein molecular weight markers. unox and ox refer to unoxidized and oxidized
proteins, respectively.
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appeared to be followed by significant rearrangements with
major re-shaping of the complex. The faster sedimenting
bshouldersQ observed at 2 and 4 h chase, absent in the 6 h
sample, could represent newly forming heterodimers on
their way to reach the native array.
Further information on the HCV structural protein
folding process could be obtained by comparing Figs. 5
and 6. Perhaps, the most surprising result from the analysis
of the gradient’s fractions by double immunoprecipitation
was the shifted position of the peaks obtained with the
conformational mAbs, that is, the E1E2 heterodimers
fraction, compared with the whole species revealed by the
polyclonal antibody. From this observation, we concluded
that a relevant amount of non-native HCV glycoproteins
was not able to attain native E1E2 heterodimer structure
within 6 h from its synthesis. Considering the two proteins
separately, at 45 min post-synthesis, the E1 peak partially
overlapped the position of the heterodimers but also showed
two additional tails. Fractions at the top of the gradient, with
lower sedimentation coefficients, included mostly oxidized
E1 (Fig. 5) that was likely represented by native unbound
monomers. From the mid to the bottom part of the gradient,
E1 was present mostly as unoxidized species (Fig. 5)
showing higher sedimentation coefficients that could be
explained by association with chaperones (calnexin) and/or
thiol oxidoreductases. In contrast, at 45 min chase, the E2
peaks were shifted towards sedimentation coefficient values
higher than the heterodimers. Thus, while a minor fraction
of oxidized E2 was associated with oxidized E1, the
majority of the molecules were still associated in higher
molecular weight complexes, possibly with unoxidized E1
but most likely with chaperones or escorts that we have not
been able to identify. At 2 h chase, the major peaks of E1
and E2 were still not overlapping, but the minor one did
coincide (Fig. 5). Since this minor E1 peak was absent in the
45 min chase, the sedimenting position of E1 was likely due
to association with E2 in pre-stable complexes with a
sedimentation coefficient of about 6.7 S. In these fractions,
indeed, native E1 co-sedimented with E2 folding inter-
mediates (Fig. 5) not recognized by the mAb (Fig. 6). At
longer periods of chase, the sedimentation positions of E1
and E2 overlapped in a unique peak, although the range of
the heterodimer sedimentation coefficients was always
lower than the total pool of E1 and E2. Assuming that the
faster sedimenting species carried down by the polyclonal
antibody were mostly non-correctly folded molecules, the
higher sedimentation coefficient could be explained by a
series of concomitant factors, such as heterogeneously
processed N-linked glycans, looser structure of the dimers,
association with chaperones or thiol oxidoreductases in
higher molecular weight complexes. Finally, the E1 and E2
detected by the polyclonal antibody in the second faster
migrating peak at 6 h post-synthesis (Fig. 5) could not be
immunoprecipitated by the anti-E2 conformational mAb
(Fig. 6).Apart from confirming the presence of a productive
folding and assembly pathway for E1 and E2 proteins,
perhaps the most striking conclusion from this experiment
was that a significant portion of the heterodimers were
released from associated factors but still appeared to deal
with the formation of native structures after 6 h from the
synthesis.Discussion
In this report, we have performed a folding and
dimerization analysis of E1 and E2 HCV proteins using
stably transfected CHO cells. In this system, the level of
expression of E1 and E2 was lower than that of several
endogenous products. Indeed, without previous immuno-
precipitation, the bands corresponding to the HCV proteins
were not detectable by SDS-PAGE in whole cell extracts.
All together, we have shown that it is possible to generate
stably transfected mammalian cell lines that are able to
sustain productive folding and assembly of the HCV
structural glycoproteins. The pathway leading to formation
of native E1E2 heterodimers appeared to be different in this
system from what found in transient transfection with over-
expressed products. In particular, the observed maturation of
E2 in the context of the heterodimer provides a molecular
basis supporting recent data indicating the dependence of E2
conformation to the coexpression of the preceding protein
E1.
During translation of the HCV polyprotein, the first
glycoprotein to emerge and enter the ER is E1. We found
that this glycoprotein had half time for oxidative folding of
about 30 min. The lectin chaperone calnexin (likely with
Erp57) assisted the unique step of E1 disulfide bond
rearrangement and dissociated immediately afterward. Fol-
lowing calnexin release, E1 underwent further structural
rearrangements and became resistant to DTT after 2 h chase.
Although E1 could exist as native monomer, it associated
with E2 in heterodimers increasingly during the time course.
The pathway of E2 folding was more elaborate and
remarkably slow. The newly synthesized protein showed a
certain degree of oxidation slowly proceeding for the first 2 h.
Between 2 and 4 h post-synthesis, E2 completed its oxidation
process, was fully included in heterodimers and the cleavage
from the E2p7 precursor reached the maximum value.
However, 2 additional hours were required to achieve the
DTT-resistant conformation, indicating that the reshuffling of
disulfide bonds was completed while the proteins were being
included in a detergent resistant E1E2 heterodimer. This
process did not involve the whole pool of E2 since a certain
amount of molecules never attained native conformation nor
were they cleaved from the E2p7 precursor. Also, we were
not able to define E2 chaperone assistance at early time post-
synthesis. Although calnexin may have assisted E2 folding
co-translationally, sedimentation analysis showed that the
unoxidized E2 species migrated in fast sedimenting fractions
M. Brazzoli et al. / Virology 332 (2005) 438–453448
M. Brazzoli et al. / Virology 332 (2005) 438–453 449after 45 min, indicating association with other components.
In these fractions, E2 may be present as aggregates or bound
to chaperone(s). Indeed, the folding of E2 could depend on
unidentified host factors, the existence of which has been
postulated several times.
Thus, in this system, oxidation kinetics of E2 (i)
paralleled the appearance of conformational epitopes, (ii)
was required for the formation of detergent-resistant E1E2
heterodimers, and (iii) was remarkably slower than E1. One
possible reason could be the higher number of cysteines
present in E2 (20 cys) as compared with E1 (8 cys). The
formation of the correct pattern of intrachain disulfide bonds
could need a longer time. However, a direct correlation
between folding kinetics and cysteine number is not found
for envelope proteins of other flaviviridae or related viruses
(Branza-Nichita et al., 2002; Lorenz et al., 2002; Molinari
and Helenius, 1999). In our opinion, the slow and difficult
folding process of E2 emerging from this study looked more
similar to the folding of the gp160/gp120 envelope protein
of HIV.
Gp160 folding was found to proceed in a remarkably
slow manner through a series of heterogeneous intermedi-
ates, although it attained a high yield of correctly folded
molecules (Land and Braakman, 2001; Land et al., 2003).
The HCV E2 and the HIV gp160 proteins display high
extent of glycosylation. In the case of HIV, while the high
density of glycosylation has been traditionally associated
with the necessity of immunoevasion, it has been recently
postulated that it could be responsible for the low folding
rate (Land and Braakman, 2001; Wei et al., 2003). We found
that the very slow E2 oxidation kinetics did not coincide
with prolonged association with calnexin and calreticulin.
One may speculate that the dense glycan coat that covers the
protein might block access to chaperones and ER folding
sensors to the protein moiety. However, apart from
functioning in chaperone recruitment, the presence of highly
hydrophilic saccharide units engenders heavy conforma-
tional preferences to the polypeptide segments in which they
are included, often resulting in a global increase of protein
solubility. From this perspective, their role overlaps
chaperone-provided assistance. We can also observe that,
once native conformation is achieved, the glycans can often
be removed without destroying overall folding (reviewed in
Helenius and Aebi, 2001). Thus, extensive glycosylation
could result in a slower folding rate, whereas this process
may represent a compromise to increase the yield of proteins
intrinsically difficult to fold. Furthermore, for the gp160
protein, a mutual dependence was assessed between folding
status and removal of the leader peptide (Li et al., 1994,
1996, 2000). The C-terminus of the structural region onFig. 6. Velocity sedimentation analysis of CBH-2 immunoprecipitated species. CH
were immunoprecipitated with anti-E2 conformational mAb CBH-2. SDS-PAGE i
the densitometric analysis (ImageQuant) of E1 and E2 proteins calculated out of 10
indicate the S20,w sedimentation coefficient standards, as determined by quantificat
marker.HCV evokes significant similarities due to the presence of
the E2-p7-NS2 precursor from which the E2p7 precursor
derives (Lin et al., 1994). However, as much as the
downstream cleavage between p7-NS2 is very efficient,
the upstream E2-p7 event results incomplete and much
slower. Thus, removal of p7 is not simply decided by a
consensus sequence but appears to require conformational
constraint. This delayed and incomplete cleavage may be an
additional indication of an intrinsic difficult folding path-
way. Notably, we found that at late time post-synthesis the
lasting E2p7 was present mostly as a smeared area of non-
native, DTT-resistant disulfide bound conformers.
A clear picture of E1E2 heterodimer formation emerged
from our data of co-immunoprecipitation and sedimentation
analysis. We have shown that both HCV glycoproteins
associated in stable heterodimers as fully oxidized species.
Quantitative analysis of heterodimer formation was assessed
by a monoclonal anti-E2 conformational-based antibody
and showed an increasing amount of the complex from 45
min to 4 h chase. Undoubtedly, a parallel exists between
time-dependent E1E2 association and E2 oxidation kinetics.
These results are consistent with the conclusion that this last
process represents the limiting step for the formation of
stable heterodimers. In addition, the amount of heterodimers
correlated with the appearance of the oxidized E2 but not
with the emergence of the DTT-resistant conformation. For
several viral envelope glycoproteins, the acquisition of a
DTT-resistant conformation in the ER has been found to be
an essential step in productive folding (Branza-Nichita et al.,
2002; Lorenz et al., 2002; Molinari and Helenius, 2000;
Opstelten et al., 1998; Tatu et al., 1993). The observation
that E2 achieved native structure while in combination with
E1 lead us to the preliminary conclusion that critical steps
for productive E2 folding may be driven by E1.
A dynamic model of E1E2 heterodimer formation
consistent with our data would be the following (Fig. 7).
E2 would be very transiently assisted by calnexin during
chain elongation and termination, after which this chaperone
dissociates from a slightly oxidized molecule (that we
referred to as E2unox). From this status, E2 slowly reaches
the oxidized conformation, maybe going through non-native
disulfide bond folding intermediates, assisted by factors that
we have been unable to identify. Subsequently, oxidized E2
forms strong interactions with an E1 molecule that has
already completed its folding process. In this complex, E2
completes its folding escorted by E1. Once formed, the
E1E2 heterodimers appeared free from associated factors.
The reshaping of the peak during the time-course could be
ascribed to reshuffling of E2 intrachain disulfide bonds and/
or subunits rearrangement. The E1 sedimentation profileO-E1E2p7 cells were treated as indicated in the legend of Fig. 5. The PNSs
n non-reducing conditions is shown on the left side. The right panels show
0% of the 19 fractions for each chase point. The arrows above the fractions
ion of a velocity sedimentation gradient run with a protein molecular weight
Fig. 7. Schematic diagram of productive E1 and E2 folding and E1E2
dimerization. (0 h): growing chains and newly synthesized HCV proteins
are assisted by calnexin. (1 h): the majority of E1 molecules are fully
oxidized and released from calnexin, while the unoxidized fraction of E1
still binds to this chaperone. The E1 molecules that have completed their
folding process are present, at least partially, as unbound monomers waiting
for an oxidized E2 to form heterodimers. The E2 molecules are still largely
unoxidized although released from calnexin. They are most likely
chaperoned by a factor(s) that we have not been able to identify. There
are few E2 molecules in an advanced status of oxidation that form
heterodimers with E1 (not represented). (2–4 h): during this period post-
synthesis, the E2 molecules complete their oxidation process, and formation
of stable heterodimers involves the whole pool of E1 and E2. However, the
dimeric complex includes native E1 and, in the large majority, non-native
E2 (DTT-sensitive). (4–6 h): E2 reaches native conformation in the context
of the heterodimer. This last achieved process involves reshaping of the
E1E2 molecule. The simultaneous presence of misfolded species evidenced
in this study is not represented in this diagram.
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monomer waiting for the delayed formation of stoichio-
metric amounts of oxidized E2.
Our data clearly showed the contemporary presence of
non-native E2 and non-native E1E2 heterodimers. This last
species was particularly striking when we compared the
sedimentation profiles obtained with the two antibodies we
used. Since this study evidenced E2 as a protein intrinsically
difficult to fold, we favor the hypothesis that E1 formed
heterodimers with E2 molecules (and likely E2p7) on theirway to misfolded pathways. According to this picture, the
faster sedimenting species of the second peak observed at 6 h
chase could result from association of non-native hetero-
dimers with cellular factors that target them to degradation.
Although this description is consistent with our observations,
we cannot rule out other hypotheses and further studies will
be required to elucidate this aspect. Taken together, these
findings are consistent with the folding mechanism of
flavivirus structural proteins in which it was found that the
preceding species on the polyprotein precursor, prM or M,
was providing folding assistance to the succeeding E protein
(Guirakhoo et al., 1992; Konishi and Mason, 1993; Lorenz et
al., 2002). They are also coherent with recent data showing
remarkable differences in several functions of E2 expressed
with or without E1 (Cocquerel et al., 2003a, 2003b). Also,
we have preliminary data in stably transfected mammalian
cells showing that, in absence of E1, E2 folding is severely
impaired (Brazzoli and Merola, unpublished).
Our data are only partially consistent with previous reports
from the literature (Choukhi et al., 1998; Deleersnyder et al.,
1997; Dubuisson and Rice, 1996). Although the kinetics of
heterodimer formation and E1 oxidation reported were
similar to what we have found, E2 folding and chaperone(s)
involvement were different. It has been reported that
oxidative folding of E2 was almost co-translational and that
heterodimer formation was delayed because of the slow
folding kinetics of E1 (Dubuisson and Rice, 1996). However,
using a conformation-sensitive anti-E2 mAb, it was found
that the appearance of native epitopes was rather slow and
much more in agreement with our data (Deleersnyder et al.,
1997). Furthermore, a prolonged association of E1, E2 and
E1E2 heterodimers was found with ER chaperones, followed
by a slow and incomplete dissociation within 6 h (Choukhi et
al., 1998; Dubuisson and Rice, 1996). The major difference
between the present study and the above reports is
represented by the level of expression of the HCV glyco-
proteins obtained in the cells. The folding studies performed
by Dubuisson et al. (1994) took advantage of the high level of
HCV protein expression driven by the Sindbis or Vaccinia
virus systems (Choukhi et al., 1998; Deleersnyder et al.,
1997; Dubuisson and Rice, 1996; Dubuisson et al., 1994) that
have the ability to shut down the synthesis of the host
proteins. While obtaining very high levels of HCV structural
proteins, viral vectors in general also generate a remarkable
amount of both hydrophobical and disulfide linked aggre-
gates (Dubuisson and Rice, 1996; Patel et al., 2001; Tsitoura
et al., 2002). Indeed, a more detailed analysis led them to
conclude that the prolonged association of E1 and E2 with
these chaperones was linked to non-productive folding
pathways (Choukhi et al., 1998). If a cellular viral infection
system is available, the reproducibility of a native folding
pathway by (an) out-of-context expressed recombinant
protein(s) can be easily assessed for different expression
systems. No such model is available for HCV. On the other
hand, it is also true that over-expressed proteins in the ER
generate in all cell types a stress-response that may result in
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Dickson, 2003)]. In stably transfected cell lines, one could
argue that the host auto-defense leads to a modified
metabolism that would change the background in which an
exogenous product reaches its mature conformation. In this
case, comparing different cell lines would reduce the
possibility of facing a cell-specific side effect. We have
performed the oxidation analysis on HuH7 stably expressing
E1, E2 and p7, obtaining substantially identical results (data
not shown). Work is in progress to analyze analogous folding
conditions in other cell types.Materials and methods
Cell culture and expression of HCV glycoproteins in CHO
cells
Stably transfected CHO cells expressing HCV structural
proteins E1, E2 and p7 (CHO-E1E2p7) or E1 and E2
(CHO-E1E2) are described in Spaete et al. (1992). Cells
were grown in a-MEM without nucleosides and ribonucleo-
sides, supplemented with 10% dialyzed fetal bovine serum
(FBS, Hyclone), antibiotics, 2 mM l-glutamine and 2 mM
l-proline.
Cell labeling and pulse-chase analysis
Subconfluent 35 or 60 mm diameter dishes of CHO,
CHO-E1E2p7 and CHO-E1E2 cells were starved for 30 min
at 37 8C in cysteine- and methionine-free medium. Cells
were pulse-labeled in presence of methionine- and cysteine-
free medium supplemented with 400 ACi ml1 of [35S]-
labeled methionine and cysteine (ProMix, Amersham
Pharmacia Biotech) for 20 min at 37 8C. The pulse period
was stopped by washing cells twice with grown medium.
For metabolic labeling, the starving step was skipped and
cells were incubated for 4–6 h in presence of 100 ACi ml1
of [35S]-labeled methionine and cysteine (ProMix). For anti-
chaperones co-immunoprecipitation, the specific activity of
labeled methionine and cysteine was 800–1000 ACi ml1.
Chase period was initiated by adding complete a-MEM
supplemented with 2.5 mM unlabeled methionine and
cysteine, 1 mM cycloheximide and incubating cells for
different chase times at 37 8C. For dithiothreitol (DTT)
resistance experiments, the regular chase was followed by 5
min incubation at 37 8C in presence of 5 mM DTT. The
same DTT concentration was used in the pulse medium for
the experiment shown in Fig. 4B, in which castanospermine
was used at 1 mM final concentration. After chase time,
cells were placed on ice, medium was removed and replaced
with ice-cold PBS containing 20 mM NEM. This alkylating
agent blocks free sulphydrilic groups and prevents further
oxidation of the cysteines (Braakman et al., 1991). After 5
min of PBS-NEM incubation, cells were lysed in 800 Al
lysis buffer, containing 1% n-Dodecyl-h-d-maltoside (h-DM, Calbiochem-Novabiochem Corporation) or Triton X-
100 in HEPES-buffered saline (HBS, pH 7.4) including
protease inhibitors cocktail (Complete, EDTA free, Roche)
and 1 mM phenylmethylsulfonyl fluoride (PMSF). After 20
min of incubation at 4 8C under agitation, total lysates were
centrifuged 10 min at 13,000  g to pellet nuclei and
cellular debris. PNSs were used for immunoprecipitation.
Antibodies, immunoprecipitation and SDS-PAGE
The two specific anti-HCV glycoproteins antibodies used
in this study consist of a polyclonal chimpanzee antiserum,
the Ch-L559, and a human monoclonal conformational anti-
E2, the CBH-2. Ch-L559 is derived from the serum of a
chimpanzee immunized with recombinant E1E2 purified
from HeLa cells infected with HCV glycoproteins whose
expression was driven by vaccinia virus (Choo et al., 1994).
This immunized chimpanzee was protected from infection
after subsequent challenge with the virus (L559 animal of
Choo et al., 1994). The IgG fraction used in this study was
purified from the serum of the L559 chimpanzee taken before
challenge with the virus. This polyclonal antiserum was able
to recognize all forms of reduced and oxidized E1 and E2 in
immunoprecipitation and Western blot, neutralize binding of
E2 and HCV pseudotype particles to cells and recognize
HCV glycoproteins in immunofluorescence studies on
permeabilized cells ((Merola et al., 2001; Rosa et al., 1996)
and data not shown). The human monoclonal anti-E2
antibody CBH-2 is one of a panel of nine conformation-
sensitive antibodies generated from peripheral B-cells of an
asymptomatic HCV infected individual (Hadlock et al.,
2000). This antibody does not recognize denatured E2,
inhibits binding of E2 to the putative receptor CD81 and
specifically recognizes properly folded E2 (Cocquerel et al.,
2003b; Hadlock et al., 2000). PNSs were precleared on
protein G coupled to Sepharose Fast Flow (Amersham
Pharmacia Biotech) for 1 h at 4 8C and were subsequently
immunoprecipitated with 1 Ag Ch-L559 (Choo et al., 1994;
Merola et al., 2001) or CBH-2 (Hadlock et al., 2000), 3 Al
anti-calnexin antiserum (Hammond and Helenius, 1994) at 4
8C overnight in presence of 10 Al Dynabeads Protein G
(Dynal Biotech ASA). The radioactive counts of the TCA-
precipitable fraction were determined on 2 Al of each
precleared lysate in triplicates. Equivalent amounts of total
labeled proteins were used for CBH-2 anti-E2 immunopre-
cipitations. The immunocomplexes were collected with the
proper magnetic device, washed three times with lysis buffer
and solubilized at 95 8C for 5 min in 20 Al of SDS loading
buffer and separated on SDS-PAGE, followed by auto-
radiography. For SDS-PAGE in reducing condition DTT 100
mM final was added to the samples.
EndoH digestion
Endoglycosidase H (endoH) cleaves ER type N-linked
high mannose sugar chains between the two N-acetylglucos-
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the glycan on the apparent molecular weight in SDS
electrophoresis (Tarentino et al., 1974). For endoH digestion
in non-reducing conditions, aliquots (5–10 Al) of the
immunoprecipitated proteins recovered from beads were
incubated with 50 mU endoH in 250 mM sodium acetate pH
5.5, in a final volume of 0.25 ml. The reaction was
performed from 6 h to overnight at 37 8C in presence of 1
mM PMSF. EndoH in reducing conditions was performed in
presence of 100 mM h-mercaptoethanol. Digested proteins
were TCA precipitated and resuspended in loading buffer
with (reducing) or without (non-reducing) 100 mM DTT for
SDS-PAGE analysis.
Sedimentation analysis
Metabolically labeled CHO cells were lysed in TEA
buffer (50 mM triethanolamine pH 8.0; 100 mM NaCl) in
presence of 1% Triton X-100. PNSs were loaded onto a 10–
40% sucrose gradient in TEA buffer plus 0.5% Triton X-
100. Samples were centrifuged 18 h at 47,000 rpm in a
Beckman TLA 50 rotor. Fractions of 250 Al were collected
by upward displacement. HCV proteins were immunopre-
cipitated and analyzed by SDS PAGE followed by auto-
radiography. S20,w sedimentation coefficients were
calculated by quantification of a velocity sedimentation
gradient run with protein molecular weight markers of
known S20,w values (Molecular Weight Marker Kit for Gel
Filtration Chromatography, Sigma Biochemicals).Acknowledgments
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